The article discusses a study showing that a top-down treatment approach, which uses biologics early in therapy, appears more effective for patients with Crohn’s disease compared to traditional step-up therapy. This method leads to better long-term outcomes by reducing inflammation and preventing complications early in the disease course. The findings suggest that early intervention with advanced therapies could improve quality of life for Crohn’s patients.
Keep Reading
Add A Comment